Notice of Change to Funding Opportunity: RFA-FD-24-029 Collaborations to Enhance Drug Development and Regulatory Science - Clinical Trials Optional
Notice Number:
NOT-FD-24-001

Key Dates

Release Date:
January 22, 2024

Related Announcements

December 28, 2023 - Collaborations to Enhance Drug Development and Regulatory Science - Clinical Trials Optional. See NOFO RFA-FD-24-029.

Issued by

FOOD AND DRUG ADMINISTRATION (FDA)

Purpose

The purpose of this Notice is to update the email address for Scientific/Research Contact Patricia Koussis from Patricia.Kroussis@fda.hhs.gov to Patricia.Koussis@fda.hhs.gov.

Currently reads:

Scientific/Research Contact(s)

Patricia Koussis
CDER 
Email: Patricia.Kroussis@fda.hhs.gov

Modified to read:

Scientific/Research Contact(s)

Patricia Koussis
CDER 
Email: Patricia.Koussis@fda.hhs.gov

All other aspects of this NOFO remain unchanged.

Inquiries

Please direct all inquiries to:

Terrin Brown
Office of Acquisitions & Grants Services (OAGS)
Food and Drug Administration
Email: Terrin.Brown@fda.hhs.gov